Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 2
1996 1
1997 6
1998 2
1999 1
2000 2
2002 4
2003 3
2004 4
2005 5
2007 1
2008 3
2009 3
2010 5
2011 6
2012 2
2013 5
2014 2
2015 2
2016 6
2017 2
2018 7
2019 1
2020 3
2021 2
2022 2
2023 0

Text availability

Article attribute

Article type

Publication date

Search Results

78 results

Results by year

Filters applied: . Clear all
Page 1
Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
Zhanel GG, Golden AR, Zelenitsky S, Wiebe K, Lawrence CK, Adam HJ, Idowu T, Domalaon R, Schweizer F, Zhanel MA, Lagacé-Wiens PRS, Walkty AJ, Noreddin A, Lynch Iii JP, Karlowsky JA. Zhanel GG, et al. Among authors: zelenitsky s. Drugs. 2019 Feb;79(3):271-289. doi: 10.1007/s40265-019-1055-2. Drugs. 2019. PMID: 30712199 Review.
Omadacycline: A Novel Oral and Intravenous Aminomethylcycline Antibiotic Agent.
Zhanel GG, Esquivel J, Zelenitsky S, Lawrence CK, Adam HJ, Golden A, Hink R, Berry L, Schweizer F, Zhanel MA, Bay D, Lagacé-Wiens PRS, Walkty AJ, Lynch JP 3rd, Karlowsky JA. Zhanel GG, et al. Among authors: zelenitsky s. Drugs. 2020 Feb;80(3):285-313. doi: 10.1007/s40265-020-01257-4. Drugs. 2020. PMID: 31970713 Review.
Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria.
Zhanel GG, Pozdirca M, Golden AR, Lawrence CK, Zelenitsky S, Berry L, Schweizer F, Bay D, Adam H, Zhanel MA, Lagacé-Wiens P, Walkty A, Irfan N, Naber K, Lynch JP 3rd, Karlowsky JA. Zhanel GG, et al. Among authors: zelenitsky s. Drugs. 2022 Apr;82(5):533-557. doi: 10.1007/s40265-022-01688-1. Epub 2022 Mar 16. Drugs. 2022. PMID: 35294769 Review.
Aminoglycoside adaptive resistance.
Karlowsky JA, Zelenitsky SA, Zhanel GG. Karlowsky JA, et al. Among authors: zelenitsky sa. Pharmacotherapy. 1997 May-Jun;17(3):549-55. Pharmacotherapy. 1997. PMID: 9165557 Review.
Ketorolac (Toradol): a marketing phenomenon.
Ariano RE, Zelenitsky SA. Ariano RE, et al. Among authors: zelenitsky sa. CMAJ. 1993 May 15;148(10):1686-8. CMAJ. 1993. PMID: 8485672 Free PMC article. No abstract available.
Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent.
Zhanel GG, Cheung D, Adam H, Zelenitsky S, Golden A, Schweizer F, Gorityala B, Lagacé-Wiens PR, Walkty A, Gin AS, Hoban DJ, Karlowsky JA. Zhanel GG, et al. Among authors: zelenitsky s. Drugs. 2016 Apr;76(5):567-88. doi: 10.1007/s40265-016-0545-8. Drugs. 2016. PMID: 26863149 Review.
Phenazopyridine in urinary tract infections.
Zelenitsky SA, Zhanel GG. Zelenitsky SA, et al. Ann Pharmacother. 1996 Jul-Aug;30(7-8):866-8. doi: 10.1177/106002809603000727. Ann Pharmacother. 1996. PMID: 8826573 Review. No abstract available.
Ceftazidime-avibactam: a novel cephalosporin/β-lactamase inhibitor combination.
Zhanel GG, Lawson CD, Adam H, Schweizer F, Zelenitsky S, Lagacé-Wiens PR, Denisuik A, Rubinstein E, Gin AS, Hoban DJ, Lynch JP 3rd, Karlowsky JA. Zhanel GG, et al. Among authors: zelenitsky s. Drugs. 2013 Feb;73(2):159-77. doi: 10.1007/s40265-013-0013-7. Drugs. 2013. PMID: 23371303 Review.
78 results